Cantor Fitzgerald Equities Analysts Reduce Earnings Estimates for Lucid Diagnostics Inc. (NASDAQ:LUCD)

Lucid Diagnostics Inc. (NASDAQ:LUCD – Free Report) – Investment analysts at Cantor Fitzgerald decreased their FY2024 earnings per share (EPS) estimates for shares of Lucid Diagnostics in a report issued on Wednesday, May 15th. Cantor Fitzgerald analyst R. Osborn now expects that the company will earn ($1.06) per share for the year, down from their […]

Related Keywords

United States , ,Nasdaq ,Lucid Diagnostics Inc ,Needham Company ,Cantor Fitzgerald ,Lucid Diagnostics ,Free Report ,Lucid Diagnostic ,Get Free Report ,Diagnostics Stock Down ,Diagnostics Inc ,Esoguard Esophageal ,Esocheck Esophageal Cell ,Lucid Diagnostics Daily ,